Enzon Inc. regulatory update

Enzon Inc. (ENZN) ENZN's Oncaspar PEG- L-asparaginase received FDA marketing approval to treat patients with acute lymphoblastic leukemia who require L-asparaginase in their treatment regimen, but ha...